Effect of Bhaskarlavan Churna in Patients with Allergic Rhinitis with a history of Habitual Suppression of Urges of Elimination: An Exploratory Single-Arm Open labelled Trial
DOI:
https://doi.org/10.47552/ijam.v17i3.7008Keywords:
Allergic-Rhinitis, Urge-suppression, TNSS, Bhaskarlavan churnaAbstract
Context: Allergic rhinitis (AR) represents one of the most prevalent inflammatory disorders in clinical practice, frequently correlated with Vataj Pratishyay (VP) in Ayurvedic medicine. Aim: This single-arm interventional study investigated the therapeutic effect of Bhaskarlavan Churna (BLC) in the management of AR precipitated by suppression of natural physiological urges of flatulence, micturition and defecation. Settings and Design: Sixty subjects (aged 20-50 years) with established AR diagnoses and documented history of habitual suppression of micturition, defecation, and flatus evacuation for a minimum duration of six months were enrolled. Material and Methods: Therapeutic intervention consisted of oral administration of BLC for seven consecutive days. Clinical assessment utilized the Total Nasal Symptom Score (TNSS) to quantify rhinorrhea, nasal obstruction, and paroxysmal sneezing. Statistical Analysis: Statistical evaluation employed Wilcoxon signed rank testing and percentage improvement calculations. Results: Pre-intervention mean symptom scores for rhinorrhea, nasal obstruction, and paroxysmal sneezing were 2.12, 0.40, and 1.05, respectively, with post-intervention values demonstrating significant reduction to 0.65, 0.08, and 0.25 (p<0.05). Among participants with histories of flatulence suppression, the highest prevalence of symptomatology was observed for rhinorrhea (91.23%), followed by paroxysmal sneezing (73.68%), and nasal obstruction (21.05%). Following BLC administration, these symptoms demonstrated marked amelioration of 69.29%, 76.19%, and 79.17%, respectively. Conclusion: The findings suggest an association between voluntary suppression of natural physiological urges and the pathogenesis of AR. Furthermore, BLC demonstrates promising therapeutic potential for symptomatic management of AR associated with such suppressions.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 International Journal of Ayurvedic Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

